Cambrex invests in Italian APIs facility
Executive Summary
Cambrex is set to invest approximately US$3 million in its Paullo plant in Milan, Italy, to “increase the capacity and efficiency” of the intermediates and active pharmaceutical ingredients (APIs) site.